Protection withheld on cost grounds: Troops 'are denied new antidote to nerve gas'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AN ANTIDOTE to all known nerve gases is being withheld from British troops on grounds of cost, according to scientists who have researched and produced it.
Foreign governments, including Canada, France, Germany, Syria and the United States, are looking towards the antidote, HI- 6, as the next generation of protection against chemical weapons but Britain has rejected it so far.
Research in Canada, France and the US has shown that HI-6 is more effective than pralidoxime mesylate (known as P2S), favoured by the British army. Both offer protection against agents such as tabun and sarin, but only HI-6 protects against soman. Like other nerve gases, soman kills within 15 minutes.
One senior toxicologist said: 'The scientists I have met at Porton Down (the Ministry of Defence research centre) would like to recommend HI-6 to the MoD but a decision has been made upstairs on grounds of cost.'
Another source close to the MoD said the ministry had bought 1.5 million P2S-filled ComboPen auto-injectors from Solvay Duphar in the Netherlands in 1990. 'It would be a brave man to recommend scrapping them all and starting again with HI-6,' he said.
Dr Derek Palmer, chairman of Phoenix, said he found the ministry's attitude 'astonishing'. 'We are the only manufacturer of HI-6 in the world, we are a British company and we want to sell to the MoD but they aren't interested.
'We have supplied Sweden with enough HI-6 for all its troops and civilians. In our opinion, Swedish civilians are now better protected than British soldiers.'
Dr Dinny Madill, head of Canadian defence research into HI-6 from 1987 to 1993, said he was puzzled by the British approach.
'We carried out extensive research into the efficacy and safety of HI-6 . . . and it performed over and above the efficiency of all other oximes (antidotes) against all known nerve agents . . . All our troops had HI-6 when they went into the Gulf war.'
Dr Graham Pearson, director- general of the MoD's Chemical and Biological Defence Establishment at Porton Down, said: 'We can see HI-6 may have some advantages and are certainly interested to see if it would give us benefits over those we already have. Once something has gone into service and is being procured, you may well find that the (MoD) procurers are not terribly interested in trying to change things because they have a stockpile.'
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments